396
GENING et al.
(2 H, t, J3, 2 = J3, 4 = 9.7, H3, H3'), 5.63 (1 H, d, J1, 2 8.4,
H1'), 5.56–5.53 (2 H, m, H4, H1), 5.38 (1H, t, J4', 5 9.6,
H4'), 4.58 (1 H, dd, H2'), 4.53 (1 H, t, H2), 4.30 (1 H,
d, J6a', 5' 5.4, J6a', 6b' 5.23, H6a'), 4.21 (1 H, dd, J6b', 5' 2.6,
H6b'), 4.11–3.95 (3 H, m, H5, H5', H6a), 3.82 (1 H, dd,
J6b, 5 6.8, J6a, 6b 10.9, H6b), 2.55 (2 H, m, SCH2CH3),
1.98 (3 H, s, CH3C(O)); 1.13 (3 H, t, J 7.8, SCH2CH3);
13C NMR: 170.55, 167.83, 167.07, 165.58, and 165.23
(five C=O), 134.21–123.57 (Ar), 98.17 (C1'), 80.84
(C1), 77.50 (C5), 71.95 (C3', C5'), 71.11 (C3), 70.24
(C4'), 69.93 (C4), 68.57 (C6), 62.51 (C6'), 54.73 (C2'),
53.93 (C2), 24.02 (SCH2CH3), 14.92 (SCH2CH3), 20.76
(CH3ë(O)).
3-(9-Fluorenylmethoxycarbonylamino)propyl-
3,3-di-O-benzoyl-2-deoxy-2-phthalimido-b-D-glu-
copyranoside (XIXa) was obtained by glycosylation
as described for disaccharide (XVI) from bromide
(XV) (0.68 mg, 1.1 mmol) and 3-Fmoc-aminopropanol
(Va) (0.3 g, 1 mmol). Deacetylation analogous to that
described for (XVII) yielded 740 mg (88%) of spac-
ered ((XIXa). [α]D –2°. 1H NMR: 7.95–7.18 (22 H, m,
Ar), 6.23 (1 H, t, J3, 2 = J3, 4 = 9.6, H3), 5.63–5.56 (2 H,
m, H1, H4), 5.15 (1 H, br. m, NH), 4.56 (1 H, t, H2),
4.39 [2 H, m, CH2 (Fmoc)], 4.21 [1 H, m, CH (Fmoc)],
3.91–3.60 (5H, m, H5, H6a, H6b, OCH2CH2CH2NH2);
3.15 (2H, m, OCH2CH2CH2NH2); 1.74 (2H, m,
OCH2CH2CH2NH2). 13ë NMR: 165.98 and 165.65
(two C=O), 156.42 [OC(O)NH], 143.98 and 141.30
(Fmoc), 134.24–119.94 (Ar), 98.34 (C1), 74.57, 70.98,
and 70.11 (C3, C4, C5), 67.29 (OCH2CH2CH2NH2);
66.34 [CH (Fmoc)], 61.33 (C6), 54.83 (C2), 47.37
(CH2 (Fmoc)], 37.64 (OCH2CH2CH2NH2); 29.51
(OCH2CH2CH2NH2).
Ethyl 6-O-(3,4-di-O-benzoyl-2-deoxy-2-phthalim-
ido-b-D-glucopyranosyl)-3,4-di-O-benzoyl-2-deoxy-
2-phthalimido-1-thio-b-D-glucopyranoside (XVII).
Absolute methanol (10 ml) and acetyl chloride (0.1 ml)
were added to a solution of 1-acetate (XVI) (520 mg,
0.47 mmol) in dichloromethane (3 ml). The reaction
mixture was stirred for 16 h at room temperature, evap-
orated, and filtered though silica gel (2 : 1 toluene–ethyl
acetate) to give 500 mg (100%) of disaccharide
(XVII); [α]D +15°; 1H NMR: 7.95–7.18 (28 H, m, Ar),
6.24–6.20 (2 H, m, H3, H3'), 5.60 (1 H, d, J1', 2' 8.5,
3-(Benzyloxycarbonylamino)propyl-3,4-di-O-
benzoyl-2-deoxy-2-phthalimido-b-D-glucopyrano-
side (XIXb) was obtained analogously to terminator
(XIXa) from bromide (XV) (530 mg, 0.85 mmol) and
3-Z-aminopropanol (Vb) (160, mg, 0.77 mmol).
Deacetylation resulted in 430 mg (80%) of terminator
(XIXb); [α]D +5°; 1H NMR: 8.78–7.14 (19 H, m, Ar),
6.30 (1 H, t, J3, 2 = J3, 4 = 9.9, H3), 5.60 (1 H, d, J1, 2 8.5,
H1), 5.53 (1 H, t, J4, 5 9.6, H4), 5.60 (2 H, br. s, PhCH2),
4.57 (1 H, dd, H2), 3.97–3.63 (5 H, m, H5, H6a,
H1'), 5.53 (1 H, d, J1, 2 10.5, H1), 5.46 (1 H, t, J4, 3
=
J4, 5 = 9.7, H4), 5.33 (1 H, t, J4', 3' = J4', 5' 9.6, H4'), 4.54
(1 H, t, J2, 3 10.4, H2), 4.42 (1 H, dd, J2', 3' 10.5, H2'),
4.03–4.15 (2 H, m, H5, H6a), 3.76–3.87 (3 H, m, H5',
H6b, H6a'), 3.64 (1 H, dd, J6b', 6a' 12.6, H6b'), 2.58 (2 H,
m, SCH2CH3), 1.13 (3 H, t, J 7.8, SCH2CH3); 13C
NMR: 165.54 (C=O), 133.97–123.54 (Ar), 97.73 (C1'),
80.93 (C1), 77.00 (C5), 74.40, 71.98, 71.00, 70.83, and
69.95 (C5, C4, C4', C3', C3), 68.47 (C6), 61.32 (C6'),
54.64 and 53.96 (C2, C2'), 23.96 (SCH2CH3), 14.93
(SCH2CH3).
OCH2CH2CH2NH2,
H6b),
3.20
(2H,
m,
OCH2CH2CH2NH2); 1.73 (2H, m, OCH2CH2CH2NH2).
13C NMR: 165.86 and 165.65 (two C=O), 156.37
[OC(O)NH], 136.65–123.56 (Ar), 98.34 (C1), 74.71,
71.14, and 70.11 (C3, C4, C5), 67.42 and 66.56
(OCH2CH2CH2N, CH2Ph); 61.38 (C6), 54.88 (C2),
37.83 (OCH2CH2CH2N); 29.56 (OCH2CH2CH2N).
6-O-(3,4-Di-O-benzoyl-2-deoxy-2-phthalimido-
b-D-glucopyranosyl)-3,4-di-O-benzoyl-2-deoxy-2-
phthalimido-b-D-glucopyranosyl bromide (XVIII).
A solution of Br2 (0.16 ml) in anhydrous CH2ël2 (1 ml)
was added to a solution of thioglycoside (XVII)
(310 mg, 0.29 mmol). The reaction mixture was stirred
for 1 h in the darkness at room temperature. The disap-
pearance of the starting thioglycoside (XVII) (Rf 0.25)
and the formation of bromide (XVIII) (Rf 0.3) was
monitored by TLC (4 : 1 toluene−ethyl acetate). The
reaction mixture was evaporated and dried in a vacuum
to give 315 mg (100%) of bromide (XVIII); 1H NMR:
7.95–7.18 (28 H, m, Ar), 6.38 (1 H, d, J1, 2 9.5, H1),
6-O-(6-O-Acetyl-3,4-di-O-benzoyl-2-deoxy-2-
phthalimido-b-D-glucopyranosyl)-1,3,4-tri-O-
benzoyl-2-deoxy-2-phthalimido-a-D-glucopyra-
nose (XX) was obtained by the Helferich reaction sim-
ilarly to disaccharide (XVI) from benzoate (XIV) (0.95 g)
and acceptor (XIII) (0.75 g); yield 1.10 g (79%); [α]D
+72°; 1H NMR: 8.15–7.18 (33 H, m, Ar), 7.09 (1 H, m,
H3), 6.34 (1 H, d, J1, 2 4.8, H1), 6.22 (1 H, m, J3, 2 10.6,
J3, 4 9.4, H3'), 5.61 (1 H, d, J1', 2' 8.4, H1'), 5.60 (1 H, dd,
J4', 5' 9.7, H4'), 5.45 (1 H, dd, J4, 5 9.7, H4), 5.02 (1 H,
dd, J2, 3 11.5, H2), 4.58 (1 H, dd, H2'), 4.48 (1 H, m,
H5), 4.27 (1 H, dd, J6a', 5' 5.1, J6a', 6b' 12.4, H6a'), 4.22 (1
H, dd, J6b', 5' 2.7, H6b'), 4.15 (1 H, dd, J6a, 5 1.8, J6a, 6b
11.3, H6a), 4.07 (1H, m, H5), 3.77 (1 H, dd, J6b, 5 6.1,
H6b); 2.05 (CH3ë(O)). 13C NMR: 170.60, 167.23,
165.56, 165.14, 165.05, and 164.69 (six C=O), 134.17–
123.30 (Ar), 98.63 (C1'), 91.19 (C1), 71.95, 71.47,
71.11, 70.45, 69.81, and 68.27 (C3, C4, C5, C3', C4',
C5'), 67.49 (C6), 62.43 (C6'), 54.60, 53.04 (C2, C2'),
20.65 (CH3ë(O)).
6.30 (1 H, t, J3', 2' = J3', 4' = 10.4, H3'), 6.14 (1 H, t, J3, 2
=
J3, 4 = 10.0, H3), 5.65 (1 H, d, J1', 2' 8.4, H1'), 5.55 (1 H,
t, J4, 5 9.8, H4), 5.38 (1 H, t, J4', 5' 9.5, H4'), 4.75 (1 H, t
H2), 4.48 (1 H, dd, H2'), 4.18–4.04 (2 H, m, H5, H6a),
3.94–3.78 (3 H, m, H5', H6b, H6a'), 3.66 (1 H, dd, J6b', 5'
4.5, J6b', 6a' 13.0, H6b'); 13C NMR: 165.95, 165.62, and
165.47 (three C=O), 134.65–123.80 (Ar), 98.24 (C1'),
78.04 (C1), 76.60, 74.49 (C5, C5'), 71.04, 70.95, and
69.97 (C3, C4, C3', C4'), 68.52 (C6), 61.26 (C6'),
58.44, and 54.64 (C2, C2').
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY Vol. 32 No. 4 2006